HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-3-methylisothiazolidine 1,1-dioxide → (R)-[2-fluoro-4-(3-methyl-1,1-dioxo-1lambda6-isothiazolidin-2-yl)phenyl][4-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]methanone
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-3-methylisothiazolidine 1,1-dioxide | HCID 16664802 | — |
| Reactant | (2-Fluoro-4-iodophenyl)[4-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]methanone | HCID 71252468 | — |
| Product | (R)-[2-fluoro-4-(3-methyl-1,1-dioxo-1lambda6-isothiazolidin-2-yl)phenyl][4-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]methanone | HCID 71252080 | 5.6% |
Reaction Steps
Using (2-fluoro-4-iodophenyl)[4-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]methanone (507 mg) described in Preparation Example 161 and (R)-3-methylisothiazolidine 1,1-dioxide (139 mg) described in Preparation Example 2 and by the reaction and treatment in the same manner as in Example 1, the title compound (29 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08816079B2 |
| Source dataset | uspto-grants-2014_08 |
| ORD ID | ord-9198820c01dd43d7a26b04b088803536 |
| Source note | uspto-grants-2014_08 |